OnKure Announces Successful Merger with Reneo Pharmaceuticals and $65 Million Private Placement

OnKure Therapeutics Announces Merger Completion and Milestones Achieved Advancing Precision Medicines in Oncology OnKure Therapeutics, a clinical-stage biopharmaceutical company based in Boulder, Colorado, is dedicated to advancing a pipeline of candidates targeting oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα), with an initial focus on breast cancer. The company recently announced the completion of its merger…

Read More

Cidara Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cidara Therapeutics, Inc. Grants Stock Options and RSUs to New Employee New Employee Receives Stock Options and RSUs Cidara Therapeutics, Inc., a biotechnology company focused on developing drug-Fc conjugate immunotherapies, recently announced that the Compensation Committee of its Board of Directors has granted Dipesh Bhatt, a new employee, a non-qualified stock option award and restricted…

Read More

Aviat Networks Announces Fiscal 2024 Fourth Quarter and Twelve Months Financial Results

Aviat Networks Reports Strong Fourth Quarter Financial Results Overview Aviat Networks, Inc. recently announced its financial results for the fourth quarter of fiscal year 2024, ending on June 28, 2024. The company reported a total revenue of $116.7 million, which represents a significant 28.1% increase compared to the same quarter last year. Additionally, the company…

Read More

Breaking News: Altamira Therapeutics Takes the Stage on Nasdaq – Get the Inside Scoop!

Ups and Downs: Altamira Therapeutics Ltd. Faces Nasdaq Listing Qualifications Issue What’s the Buzz in the Stock Market? Hamilton, Bermuda, Oct. 04, 2024 (GLOBE NEWSWIRE) — Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq: CYTO) recently made headlines when it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)…

Read More

Attention Investors: Don’t Miss Out on PDD Holdings Inc.’s October 15, 2024 Deadline! Let’s Get This Bread!

Investors Beware: Securities Class Action Lawsuits Filed Against Pinduoduo Inc. What’s the Buzz About? Hold onto your seats, investors! The law firm of Kessler Topaz Meltzer & Check, LLP has dropped a bombshell with the filing of securities class action lawsuits against Pinduoduo Inc. This news has sent shockwaves through the investment community, leaving many…

Read More

Unlocking the Potential: Why Investing in Micron is a Smart Move for Riding the Upturn in the Memory Chip Market

Micron Technology: A Tech Stock Worth Investing In Recent Underperformance and Future Potential Despite recent underperformance in the chip sector, Micron Technology remains a strong buy for investors. The company’s stock has been impacted by short-term concerns and inventory buildup by manufacturers, leading to challenges in raising prices immediately. However, the long-term outlook for Micron…

Read More